Curated News
By: NewsRamp Editorial Staff
September 12, 2024
Aclarion, Inc. Announces Significant Milestones in Establishing Nociscan as Standard of Care for Chronic Low Back Pain
Discuss on Reddit
Discuss on SubstackTLDR
- Investment in Aclarion AI platform exceeds $50 Million, providing a significant advantage in the healthcare technology sector
- Aclarion's Nociscan uses MRI data and AI algorithms to identify painful discs, revolutionizing chronic low back pain diagnosis
- Nociscan's success and payer coverage decisions lead to better patient care, potentially transforming standard of care for chronic low back pain
- Aclarion's partnership with KOL surgeons and success in gaining payer coverage represents a disruptive advancement in healthcare technology
Impact - Why it Matters
The news is important as it highlights the potential transformation of spine care through the innovative Nociscan technology, offering hope for improved diagnosis and treatment of chronic low back pain. This development could have significant implications for the healthcare sector and individuals suffering from this prevalent condition.
Summary
Aclarion, Inc. provided a corporate update highlighting recent achievements and future milestones in their effort to establish Nociscan as a standard of care for chronic low back pain. The company has reached key milestones such as peer-reviewed publications, commercial agreements, and payer coverage decisions, positioning Nociscan as a disruptive technological advancement in the healthcare sector. With over $50 million invested in the Aclarion AI platform, the company aims to address the $134 billion annual expenditure on chronic low back pain in the US healthcare system.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Aclarion, Inc. Announces Significant Milestones in Establishing Nociscan as Standard of Care for Chronic Low Back Pain
